Literature DB >> 6966155

Enzyme-induced modification of the surface properties of lymphoid cells in malignant disease. I. Effect of trypsin on rosette formation by lymphocytes in myelomatosis.

J O Fajumi.   

Abstract

The surface properties of blood lymphocytes from treated myeloma patients and healthy controls were studied in vitro. The patients were tested 6 weeks after the last treatment to allow time for cells to recovery from possible drug toxicity. Peripheral-blood lymphocytes were tested for rosette formation with unsensitized sheep erythrocytes (E rosettes) and with complement and antibody-coated erythrocytes (EAC rosettes). The tests were duplicated using lymphocytes pretreated with trypsin. As others have noted, myelomatosis is associated with increased blood levels of EAC-rosette-forming cells and a marked reduction in E-rosette-forming cells. E-rosette formation was significantly increased by pretreatment of myeloma lymphocytes with trypsin. By contrast, enzyme-treated cells showed no significant change in EAC-rosette formation. These results suggest that the absolute number of circulating T cells is probably not reduced in myelomatosis, but that the surface of T cells is somehow modified so that a proportion of them lose the ability to form E rosettes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966155      PMCID: PMC2010201          DOI: 10.1038/bjc.1980.28

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells.

Authors:  T Nemoto; T Han; J Minowada; V Angkur; A Chamberlain; L Dao
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

2.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

3.  In vitro studies of lymphocytes from patients with plasma cell myeloma. II. Characterization by cell surface markers.

Authors:  H Mellstedt; M Jondal; G Holm
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

4.  The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells.

Authors:  U Galili; M Schlesinger
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

5.  In vitro studies of lymphocytes from patients with plasma cell myeloma. I. Stimulation by mitogens and cytotoxic activities.

Authors:  H Mellstedt; G Holm
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

6.  The human rosette-forming cell as a marker of a population of thymus-derived cells.

Authors:  J Wybran; M C Carr; H H Fudenberg
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

7.  Combination therapy for myelomatosis.

Authors:  L Azam; I W Delamore
Journal:  Br Med J       Date:  1974-12-07

8.  Effects on C-reactive protein on the lymphoid system. I. Binding to thymus-dependent lymphocytes and alteration of their functions.

Authors:  R F Mortensen; A P Osmand; H Gewurz
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

9.  A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization.

Authors:  C Bianco; R Patrick; V Nussenzweig
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.